The human cathelicidin LL-37 and chicken-derived CATH-B1 strongly inhibited porcine epidemic diarrhea virus at non-toxic concentrations by disrupting virus particles, while four pig-derived antimicrobial peptides showed no antiviral effect.
5-10 µMNon-toxic concentration at which LL-37 and CATH-B1 significantly reduced PEDV infection in cell culture
What the researchers found
LL-37 (human) and CATH-B1 (chicken) cathelicidins significantly reduced PEDV infection of Vero cells at non-toxic concentrations of 5 and 10 µM, effective in both co-incubation (simultaneous) and pre-incubation setups. Transmission electron microscopy revealed that both peptides directly altered virus morphology and caused aggregation of viral particles, reducing infectivity.
Fluorogenic LL-37 was observed entering cells, suggesting a possible immunomodulatory component to its antiviral action. In stark contrast, none of the four porcine cathelicidins (PMAP-36, PMAP-23, PR-39, PG-1) showed any inhibitory effects against PEDV, even at higher concentrations.
Why it matters
PEDV causes massive losses in the global pig industry and no effective antiviral treatments exist. This study identifies two cathelicidin peptides that effectively neutralize the virus and reveals their mechanism — direct disruption of viral particles. The surprising finding that pig-derived peptides don't work against a pig virus while human and chicken peptides do raises important questions about host-pathogen co-evolution and could guide development of novel antiviral peptide therapies.
How the study worked
The researchers tested six cathelicidin antimicrobial peptides against GFP-tagged PEDV in Vero cell cultures. Antiviral activity was measured using flow cytometry and fluorescent microscopy in both co-incubation and pre-incubation setups. Peptide entry into cells was tracked using fluorogenic LL-37. Virus morphology changes were visualized with transmission electron microscopy. Cytotoxicity was assessed to ensure peptides were used at non-toxic concentrations.
What this study cannot tell us
This is an in vitro study using Vero cells (monkey kidney cells), not pig intestinal cells where PEDV naturally infects. The study does not include in vivo animal experiments, so it is unknown whether LL-37 or CATH-B1 could effectively treat PEDV infection in live pigs. The concentrations effective in cell culture may not be achievable in the pig gut. Additionally, PEDV primarily infects intestinal epithelium, and peptide stability in the GI environment was not assessed.
How to read the evidence
This is an in vitro laboratory study using cell cultures. While the experimental methods are rigorous (flow cytometry, TEM, fluorescent microscopy), no animal or clinical data is presented, placing this at an early preclinical evidence level.
When this study was published
Published in 2024, this is recent work that builds on growing interest in antimicrobial peptides as antiviral agents following the COVID-19 pandemic.
The bigger picture
Antimicrobial peptides are increasingly studied as potential antiviral agents, especially against coronaviruses. LL-37 has already shown activity against multiple viruses including influenza and SARS-CoV-2. This study extends that work to a veterinary coronavirus and reveals that the antiviral mechanism involves direct physical disruption of virus particles. The species-specific differences in efficacy also highlight that antimicrobial peptide evolution is shaped by the specific pathogens each species faces.
Questions still open
- Why did the pig's own cathelicidins fail against PEDV — has the virus evolved to evade its host's innate antimicrobial peptides?
- Could LL-37 or CATH-B1 be delivered effectively to the pig intestine where PEDV infects?
- Do these cathelicidins show similar efficacy against other coronaviruses, including human ones?
Common questions
What are cathelicidins and why are they interesting as antivirals?
Why couldn't the pig's own defense peptides stop a pig virus?
Read the original research
Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy.
Virus research, 350, 199496
Citation
Pashaie, Fatemeh; Hoornweg, Tabitha E; Bikker, Floris J; Veenendaal, Tineke; Broere, Femke; Veldhuizen, Edwin J A. (2024). Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy.. Virus research, 350, 199496. https://doi.org/10.1016/j.virusres.2024.199496